Journals / Kocaeli Tıp Dergisi / 2017 / Cilt: 6 - Sayı: 2

Sexual Dysfunction in Women with Polycystic Ovary Syndrome

Polikistik Over Sendromlu Kadınlarda Cinsel Disfonksiyonun Değerlendirilmesi

Pages
17–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The subpopulation of women with PCOS whose serum testosterone levels are in the normal reproductive range are at increased risk for sexual dysfunction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: To compare the differences in sexual function between women with PCOS and controls, and to assess the relationship of serum testosterone, body mass index (BMI), hirsutism, and acne with sexual function scores in women with PCOS.
📊
Key Findings & Data:RESULTS: The differences between for the total FSFI scores were not statistically different, the mean FSFI scores for women with PCOS were lower in every category as compared with controls, but the differences were only statistically significant for orgasm.(4.44±0.07, p 1 standard deviation above the mean had significantly better sexual functioning DISCUSSION and CONCLUSION: Women with PCOS have similar sexual functioning scores compared with controls except in regard to orgasm.
💡
Conclusion & Impact:The subpopulation of women with PCOS whose serum testosterone levels are in the normal reproductive range are at increased risk for sexual dysfunction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: To compare the differences in sexual function between women with PCOS and controls, and to assess the relationship of serum testosterone, body mass index (BMI), hirsutism, and acne with sexual function scores in women with PCOS. METHODS: A cross-sectional analysis in which women who met the Rotterdam criteria for PCOS were compared with a group of healthy volunteers. Results from the validated Female Sexual Dysfunction Index(FSFI) were used to assess sexual function. In women with PCOS, serum testosterone levels, BMI, self-reported hirsutism, and acne were assessed as independent variables. RESULTS: The differences between for the total FSFI scores were not statistically different, the mean FSFI scores for women with PCOS were lower in every category as compared with controls, but the differences were only statistically significant for orgasm.(4.44±0.07, p 1 standard deviation above the mean had significantly better sexual functioning DISCUSSION and CONCLUSION: Women with PCOS have similar sexual functioning scores compared with controls except in regard to orgasm. The subpopulation of women with PCOS whose serum testosterone levels are in the normal reproductive range are at increased risk for sexual dysfunction.

Özet

GİRİŞ ve AMAÇ: Polikistik Over Sendromu(PKOS) olan kadınlarla, kontrol grubu arasında seksüel disfonksiyon skorları açısından fark olup olmadığını ve ayrıca PKOS lu kadınlarda seksüel disfonksiyon skorlarının serum testosteron ve body mass indeksi arasındaki ilişkiyi değerlendirdik YÖNTEM ve GEREÇLER: PKOS için Roterdam kriterlerini karşılayan kadınlarla kontrol grubu arasında seksüel fonksiyon değerlendirilmesinde kadın cinsel disfonkiyon indeksi (FSFI) kullanıldı. PKOS lu kadınlarda serum testosteron seviyeleri ve Body mass indeks değerleri bağımsız değişkenler olarak değerlendirildi BULGULAR: Total FSFI skorları arasında istatistiksel olarak anlamlı fark bulunmadı. Ortalama FSFI skorları PKOS lu kadınlarda her kategoride düşük olarak saptanmasına rağmen istatistiksel olarak sadece orgasm skoru için anlamlı fark bulundu.( 4.44±0.07, p 1 olan PKOS lu hastalar belirgin olarak daha iyi seksüel fonksiyonlara sahip olduğu bulundu. BMI ile FSFI skorları arasından belirgin bir fark saptanmadı. TARTIŞMA ve SONUÇ: PKOS lu kadınlar ile kontrol grubundaki kadınlar orgasm skorları dışında benzer seksüel fonksiyonlara sahip olduğu saptandı. PKOS lu kadınlarda serum testosterone seviyeleri normal reprodüktif çağdaki hastalarla aynı olanlar seksüel disfonksiyon açısından risk grubuna girmektedir.

🔖

Cite This Article

DOĞAN, O., YILDIZ, A. (2017). Sexual Dysfunction in Women with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi, Cilt: 6 - Sayı: 2, 17–23. https://ajindex.com/articles/211170

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. de Niet JE, de Koning CM, Pastoor H, et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010; 25: 1497-1503
  2. Jones GL, Hall JM, Balen AH, et al. Healthrelated quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 2008; 14: 15-25
  3. Hemati T, Moghadami-Tabrizi N, Salmanian B, et al. High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome. Iran J Reprod Med 2011; 9: 223-8
  4. Mansson M, Norstrom K, Holte J, et al. Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Biol 2011; 155: 161-5
  5. Sundararaman PG, Shweta, Sridhar GR. Psychosocial aspects of women with polycystic ovary syndrome from south India. J Assoc Physicians India 2008; 56: 945-8
  6. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf) 2007; 66: 373-9
  7. Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 5801-7
  8. Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. Health Psychol 2006; 11: 613-25
  9. Benson S, Hahn S, Tan S, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod 2009; 24: 1446-51
  10. Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological wellbeing in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279-86
  11. Battaglia C, Nappi RE, Mancini F, et al. PCOS, sexuality, and clitoral vascularisation: a pilot study. J Sex Med 2008; 5: 2886-94
  12. Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 5801-7
  13. Rassi A, Veras AB, dos Reis M, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Comp Psychiatry 2010; 51: 599-602 14. Rasgon NL, Rao RC, Hwang S, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003; 74: 299-304
  14. Kennedy SH, Dickens SE, Eisfeld BS, et al. Sexual dysfunction